Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -6.35x is 93% above its 4-year average of -94.87x, near the high end of its 4-year range (-1160.00x–-0.85x).
As of the fiscal period ended Friday, June 30, 2023. 96.92% below its 12-month average of -3.23x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2023 (2023-06-30): -6.35x.
INTEREST COVERAGE RATIO
-6.35x
INTEREST COVERAGE RATIO AVG TTM
-3.23x
INTEREST COVERAGE RATIO AVG 3Y
-109.17x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-96.92%
CURRENT VS 3Y AVG
+94.18%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.12x
median of 422 covered companies
CURRENT VS SECTOR MEDIAN
-24.21%
vs the sector median at left
GRI Bio, Inc.
Market Cap
$4.13M
Interest Coverage Ratio
-6.35x
TTM Avg
-3.23x
3Y Avg
-109.17x
5Y Avg
N/A
Market Cap
$4.12M
Interest Coverage Ratio
N/A
TTM Avg
11.42x
3Y Avg
11.42x
5Y Avg
7.97x
Market Cap
$4.05M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.22M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$4.08M
Interest Coverage Ratio
-345.15x
TTM Avg
1.19x
3Y Avg
1.19x
5Y Avg
1.19x
Market Cap
$4.33M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$4.40M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | $4.13M | -6.35x | -3.23x | -109.17x | N/A |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.12M | N/A | 11.42x | 11.42x | 7.97x |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.05M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.22M | -21.32x | 128.62x | 128.62x | 128.62x |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.08M | -345.15x | 1.19x | 1.19x | 1.19x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.33M | -765.53x | 1.76x | 1.76x | 1.76x |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.40M | N/A | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.68M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.53M | N/A | N/A | N/A | N/A |
Interest Coverage
-6.4x
Debt/Equity
0.00
Current Ratio
10.30
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-06-30 | -6.35x |
| 2023-03-31 | -0.85x |
| 2022-12-31 | -6.02x |
| 2022-09-30 | -1.13x |
| 2022-06-30 | -1.78x |
| 2022-03-31 | -198.00x |
| 2021-12-31 | -114.50x |
| 2021-09-30 | -313.25x |
| 2021-06-30 | -1155.00x |
| 2021-03-31 | -325.25x |
| 2020-12-31 | -162.22x |
| 2020-09-30 | -86.08x |
| 2020-06-30 | -94.58x |
| 2020-03-31 | -1160.00x |
| 2019-09-30 | -6.14x |
| 2019-06-30 | -11.96x |
